Dr. Robert J Petrokubi, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 12500 Mayo Ct, Prospect, KY 40059 Phone: 502-228-2793 Fax: 502-228-2793 |
News Archive
The right way is to strengthen it, closing coverage gaps while also bringing down costs by improving care and reducing waste and fraud. Medicare's trustees estimate that the new health care law has already added eight years to the life of the Medicare trust fund by doing just that. The president's fiscal framework would put the program on even more solid ground in the future.
In a peer-reviewed published study, a new medically engineered pressure-technology disposable adhesive device (Pressure Right-) developed by Pressure Point Inc. has clinically proven to enhance the efficacy of a popular prophylactic antiemetic drug combination in reducing the incidence of postoperative nausea and vomiting (PONV) among high-risk patients after major laparoscopic surgery procedures.
Mylan Inc. today confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc. have been sued by Schering Corporation and MSP Singapore Company in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg. This product is the generic version of Vytorin® Tablets, a cholesterol treatment.
Chemical engineers from Johns Hopkins University have broken the "mucus barrier," engineering the first drug-delivery particles capable of passing through human mucus - regarded by many as nearly impenetrable - and carrying medication that could treat a range of diseases. Those conditions include lung cancer, cervical cancer and cystic fibrosis, the research noted in a presentation scheduled for the 236th National Meeting of the American Chemical Society.
› Verified 8 days ago